NIH – NCI Outstanding Investigator Award (R35)

October 3, 2017 by School of Medicine Webmaster

The purpose of the National Cancer Institute (NCI) Outstanding Investigator Award is to provide long-term support and increased flexibility for investigators with outstanding records of research productivity to continue or to embark upon a research program of unusual potential in cancer. Candidates for the OIA must be nominated by their applicant organization. Special features of the OIA include 7-year project periods; the expectation that the OIA PD/PI commit at least 6 person months effort to the OIA; the expectation of clear and substantial Institutional commitment to the PD/PI, for example, providing 20% of salary support; and that PD/PIs will be expected to renegotiate their time and effort on all other grant support, including NIH grants, in order to accommodate the OIA level of effort.  It is expected that the OIA will replace current NCI funding on individual research grants.  The NCI will only consider funding two additional research project grants to the Outstanding Investigator while the OIA is active.  This limit includes single PD/PI, multiple PD/PI and multi-project grants where the OIA Investigator is the PD/PI.

Deadlines:  November 28, 2017 (letters of intent due 30 days prior to deadline)


Filed Under: Funding Opportunities